accountISI Group biotechnology analyst Mark Schoenebaum writes that Obama "appears to be proposing to allow Medicare to negotiate drug prices��� and that this would require a new law, because such negotiations are currently prohibited. Schoenebaum then...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Obama Re-Opens Health Reform Debate
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account